Photothermal therapy co-localized with CD137 agonism improves survival in an SM1 melanoma model without hepatotoxicity-Reference-Cited by-同舟云学术

Photothermal therapy co-localized with CD137 agonism improves survival in an SM1 melanoma model without hepatotoxicity

Published:2024-09-03 Issue: Volume: Page:1-16
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Medina Jacob A¹²^ORCID,Ledezma Debbie K¹²^ORCID,Ghofrani Joshua¹²^ORCID,Chen Jie²,Chin Samantha J¹²^ORCID,Balakrishnan Preethi Bala²^ORCID,Lee Norman H¹²³^ORCID,Sweeney Elizabeth E²⁴^ORCID,Fernandes Rohan¹²⁵^ORCID

Affiliation:

1. Integrated Biomedical Sciences Program, School of Medicine & Health Sciences, George Washington University, WA 20037, USA

2. The George Washington Cancer Center, George Washington University, WA 20052, USA

3. Department of Pharmacology & Physiology, School of Medicine & Health Sciences, George Washington University, WA 20037, USA

4. Department of Biochemistry & Molecular Medicine, School of Medicine & Health Sciences, George Washington University, WA 20037, USA

5. Department of Medicine, School of Medicine & Health Sciences, George Washington University, WA 20037, USA

Funder

National Cancer Institute, National Institutes of Health

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17435889.2024.2389770

Reference55 articles.

1. NIR-I-to-NIR-II fluorescent nanomaterials for biomedical imaging and cancer therapy

2. Nanoshell-Enabled Photothermal Cancer Therapy: Impending Clinical Impact

3. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

4. Plasmonic photothermal therapy (PPTT) using gold nanoparticles

5. In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity